Equities

Sotera Health Co

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SHC:NSQ

Sotera Health Co

Actions
Health CareMedical Equipment and Services
  • Price (USD)15.70
  • Today's Change-0.21 / -1.32%
  • Shares traded1.22m
  • 1 Year change+34.42%
  • Beta1.8759
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

  • Revenue in USD (TTM)1.16bn
  • Net income in USD77.95m
  • Incorporated2015
  • Employees3.00k
  • Location
    Sotera Health Co9100 South Hills BlvdSuite 300, Suite 300BROADVIEW HEIGHTS 44147United StatesUSA
  • Phone+1 (440) 262-1410
  • Fax+1 (302) 636-5454
  • Websitehttps://soterahealth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
National Healthcare Corp1.52bn120.02m2.66bn15.28k22.312.4915.881.757.677.6797.0168.790.995109.4311.0799,344.228.046.459.607.7939.3138.818.087.331.79--0.035939.9816.098.1017.7523.4410.754.24
CorVel Corp941.49m105.73m2.68bn5.08k25.687.1419.602.852.042.0418.187.351.59--9.04185,515.9017.8716.1629.5226.6624.2222.6011.239.71----0.000.0012.618.6224.8014.972.02--
Lifestance Health Group Inc1.42bn9.66m2.78bn10.96k305.001.8243.201.950.02340.02343.623.920.659--12.52129,941.200.4471-7.410.5031-8.11----0.6785-14.39--2.290.1557--13.8530.44116.82---1.04--
Privia Health Group Inc2.12bn22.92m2.97bn1.23k135.504.0374.961.400.17740.177416.485.961.69--5.921,731,519.002.37-3.024.29-5.099.879.521.40-1.72----0.00--22.2621.0459.33-6.01----
Concentra Group Holdings Parent Inc2.16bn164.17m3.05bn9.97k18.487.7612.271.411.281.2816.913.060.8043--9.10217,058.006.43--7.38--28.34--7.99----3.160.7892--13.85---1.42------
Brookdale Senior Living Inc3.19bn-262.69m3.60bn22.44k----33.451.13-1.12-1.1213.58-0.18820.5199--53.43142,338.10-4.28-3.23-4.72-3.5926.2223.32-8.23-6.65--0.43281.01--2.19-2.04-30.09---4.88--
Hims & Hers Health Inc2.35bn128.37m3.76bn2.44k31.946.9220.531.600.5160.5169.222.381.648.50122.82961,358.308.971.8511.482.3273.8477.065.471.051.70--0.6426--59.00--1.85------
Alignment Healthcare Inc3.95bn-724.00k4.01bn1.85k--22.38136.061.02-0.0092-0.009219.430.87824.27--19.402,135,597.00-0.1059-18.62-0.2085-31.5812.3711.73-0.0248-5.62--1.080.6432--46.0632.7199.43--11.26--
Sotera Health Co1.16bn77.95m4.52bn3.00k58.707.4716.393.890.2710.2714.072.130.367410.017.29387,872.302.460.37882.640.422955.4855.276.701.092.242.660.78690.005.747.3075.79--20.87--
Option Care Health Inc5.65bn207.59m4.94bn6.53k24.843.7417.770.87511.271.2734.578.461.6410.6212.79865,428.806.046.267.887.7919.2621.173.674.370.95727.170.46670.0013.0313.25-2.00--8.98--
Chemed Corp2.53bn265.24m5.80bn15.81k22.935.9017.572.2918.3818.38174.8971.431.58216.9314.30160,013.8016.5417.8520.1422.2032.5434.8810.4811.811.03--0.01119.304.064.00-12.17-3.651.3110.76
Radnet Inc1.97bn-12.71m5.82bn8.55k--5.4734.512.96-0.1828-0.182825.5313.740.5676--8.71230,470.300.6171.200.79071.5921.3322.021.091.90--1.320.45490.0013.189.65-8.25-28.3220.46--
PACS Group Inc5.14bn169.04m5.94bn45.68k36.556.7926.871.161.031.0331.455.561.01--8.54112,496.503.31--4.07--21.38--3.27----12.190.3813--31.44---50.60------
Data as of Mar 03 2026. Currency figures normalised to Sotera Health Co's reporting currency: US Dollar USD

Institutional shareholders

49.19%Per cent of shares held by top holders
HolderShares% Held
Darsana Capital Partners LPas of 31 Dec 202526.00m9.15%
Sculptor Capital LPas of 31 Dec 202521.00m7.39%
Sessa Capital IM LPas of 31 Dec 202520.55m7.23%
The Vanguard Group, Inc.as of 31 Dec 202517.65m6.21%
BlackRock Fund Advisorsas of 31 Dec 202516.62m5.85%
Sachem Head Capital Management LPas of 31 Dec 202511.65m4.10%
T. Rowe Price Investment Management, Inc.as of 31 Dec 20258.86m3.12%
Janus Henderson Investors US LLCas of 31 Dec 20256.63m2.33%
SSgA Funds Management, Inc.as of 31 Dec 20255.97m2.10%
Dimensional Fund Advisors LPas of 31 Dec 20254.81m1.69%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.